Disclosure 0000907654-26-000104-3

SEC FORM 4

$718,754.98

Oruka Therapeutics, Inc. (ORKA)

Sale of 8,554 shares at $84.0256 per share.

Reporting Person Klein Lawrence Otto · Officer Title Chief Executive Officer · Transaction Code S

Traded Oct 1, 2026 · Disclosed Oct 2, 2026

Source: SEC Form 4 · 0000907654-26-000104 · filed 2026-10-02 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Oruka Therapeutics, Inc. (ORKA)." Disclosed 2026-10-02. https://desqlong.com/cards/0000907654-26-000104-3 (retrieved 2026-10-03).